141 related articles for article (PubMed ID: 6490174)
1. [Antibacterial activity of clindamycin and lincomycin in broth, serum, and in combination with polymorphonuclear leukocytes against Staphylococcus aureus and Staphylococcus epidermidis].
Bassler M; Just HM; Richter A; Zeller H; Daschner F
Infection; 1984; 12(4):280-5. PubMed ID: 6490174
[TBL] [Abstract][Full Text] [Related]
2. Effect of ceftriaxone on Pseudomonas aeruginosa and Staphylococcus aureus in broth, serum, and in combination with human polymorphonuclear leukocytes.
Bassler M; Blaschke H; Just M; Daschner FD
Chemotherapy; 1982; 28(5):390-6. PubMed ID: 6291868
[TBL] [Abstract][Full Text] [Related]
3. Microbial kinetics of drug action against gram-positive and gram-negative organisms. III: Effect of lincomycin and clindamycin combinations on Staphylococcus aureus and Escherichia coli.
Heman-Ackah SM
J Pharm Sci; 1975 Oct; 64(10):1621-6. PubMed ID: 1102659
[TBL] [Abstract][Full Text] [Related]
4. [In vitro activity of linezolid, moxifloxacin, levofloxacin, clindamycin and rifampin, alone and in combination, against Staphylococcus aureus and Staphylococcus epidermidis].
Soriano A; Jurado A; Marco F; Almela M; Ortega M; Mensa J
Rev Esp Quimioter; 2005 Jun; 18(2):168-72. PubMed ID: 16130039
[TBL] [Abstract][Full Text] [Related]
5. Activity of clindamycin against Staphylococcus aureus and Staphylococcus epidermidis from four UK centres.
Reeves DS; Holt HA; Phillips I; King A; Miles RS; Paton R; Wise R; Andrews JM
J Antimicrob Chemother; 1991 Apr; 27(4):469-74. PubMed ID: 1856126
[TBL] [Abstract][Full Text] [Related]
6. Different kinetic of enzymatic inactivation of lincomycin and clindamycin in Staphylococcus aureus.
Barcs I
J Chemother; 1993 Aug; 5(4):215-22. PubMed ID: 8229148
[TBL] [Abstract][Full Text] [Related]
7. MIC and serum bactericidal activity of clindamycin against methicillin-resistant and -sensitive staphylococci.
Lemmen S; Kropec A; Engels I; Busse A; Daschner FD
Infection; 1993; 21(6):407-9. PubMed ID: 8132374
[TBL] [Abstract][Full Text] [Related]
8. In vitro studies of the pharmacodynamics of teicoplanin against Staphylococcus aureus, Staphylococcus epidermidis and Enterococcus faecium.
Odenholt I; Löwdin E; Cars O
Clin Microbiol Infect; 2003 Sep; 9(9):930-7. PubMed ID: 14616681
[TBL] [Abstract][Full Text] [Related]
9. [Comparison of the in vitro activity of ceftazidime: in culture, in serum and in combination with granulocytes].
Daschner FD; Bassler M; Grundau D; Dieterle L; Just HM
Immun Infekt; 1983 Nov; 11(6):221-8. PubMed ID: 6439624
[TBL] [Abstract][Full Text] [Related]
10. Effect of azlocillin and piperacillin in subinhibitory and inhibitory concentrations on Staphylococcus aureus and Pseudomonas aeruginosa in broth, in serum and in the presence of human polymorphonuclear leukocytes.
Bassler M; Depuis W; Utz E; Just HM; Daschner FD
Eur J Clin Microbiol; 1983 Oct; 2(5):439-44. PubMed ID: 6416838
[TBL] [Abstract][Full Text] [Related]
11. [In-vitro activity of clindamycin and lincomycin in the presence of Staphylococcus aureus].
Wiedemann B
Fortschr Med; 1984 Jun; 102(21):603-4. PubMed ID: 6469163
[No Abstract] [Full Text] [Related]
12. Clindamycin at subinhibitory concentrations enhances antibody- and complement-dependent phagocytosis by human polymorphonuclear leukocytes of Staphylococcus aureus.
Veringa EM; Verhoef J
Chemotherapy; 1987; 33(4):243-9. PubMed ID: 3608624
[TBL] [Abstract][Full Text] [Related]
13. Cellular uptake of clindamycin and lincomycin.
Easmon CS; Crane JP
Br J Exp Pathol; 1984 Dec; 65(6):725-30. PubMed ID: 6498086
[TBL] [Abstract][Full Text] [Related]
14. Susceptibility of bacteria to serum lysis or phagocytosis following growth in subinhibitory levels of lincosaminide or spectinomycin related antibiotics.
Cialdella JI; Vavra JJ; Marshall VP
J Antibiot (Tokyo); 1986 Jul; 39(7):978-84. PubMed ID: 2944862
[TBL] [Abstract][Full Text] [Related]
15. [Sensitivity of hospital strains of Staphylococcus aureus to lincomycin and clindamycin].
Jakubicz P; Dzierzanowska D
Pol Tyg Lek; 1980 Feb; 35(8):269-71. PubMed ID: 7360703
[No Abstract] [Full Text] [Related]
16. [The effect of clindamycin on intraphagocytic Staphylococcus aureus in leukocytes from patients with chronic osteomyelitis].
Burgaleta C; Velasco GL; Peletier R; Messeguer M; Pernas M
Enferm Infecc Microbiol Clin; 1992 Mar; 10(3):143-7. PubMed ID: 1576187
[TBL] [Abstract][Full Text] [Related]
17. Antibiotic susceptibility patterns of Staphylococcus aureus and Staphylococcus epidermidis.
Deng LJ; Luh KT; Hsieh WC; Ho SW
Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1981 Mar; 14(1):1-9. PubMed ID: 7261697
[TBL] [Abstract][Full Text] [Related]
18. Microbial kinetics of drug action against gram-positive and gram-negative organisms. II: Effect of clindamycin on Staphylococcus aureus and Escherichia coli.
Heman-Ackah SM
J Pharm Sci; 1975 Oct; 64(10):1612-20. PubMed ID: 241826
[TBL] [Abstract][Full Text] [Related]
19. In vitro activity of sulbactam/ampicillin and ampicillin against methicillin-sensitive and methicillin-resistant Staphylococcus aureus and Staphylococcus epidermidis.
Fabbri A; Tacchella A; Belli ML; Losurdo G
Chemioterapia; 1988 Oct; 7(5):306-8. PubMed ID: 3224398
[TBL] [Abstract][Full Text] [Related]
20. Clindamycin as an anti-staphylococcal agent--indications and limitations.
Hedström SA
Scand J Infect Dis Suppl; 1984; 43():62-6. PubMed ID: 6598522
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
